Accredited Investors Inc. Bausch Health Companies Inc. Transaction History

Accredited Investors Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 21, 2022	SELL	$7.06 - $23.63 $67,211 - $224,957	-9,520 Closed	0 $0
Q1 2021 Apr 16, 2021	BUY	$21.37 - $34.38 $203,442 - $327,297	9,520 New	9,520 $302,000
Q1 2020 May 15, 2020	SELL	$12.98 - $30.25 $123,569 - $287,980	-9,520 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$20.88 - $25.66 $19,731 - $24,248	-945 Reduced 9.03%	9,520 $208,000
Q2 2019 Aug 13, 2019	BUY	$20.52 - $26.45 $214,741 - $276,799	10,465 New	10,465 $0

255

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.88B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Accredited Investors Inc., based on Form 13F filings with the SEC.

Stay updated on Accredited Investors Inc. with notifications on news.